Anagenics Limited (ASX:AN1)
Cellmid Limited (ASX:CDY) is a health and beauty-tech business engaged in the development and sale of clinically validated anti-aging products for hair, skin and body.
Cellmid has a strong track record of developing first in class and best in class anti-ageing solutions. In a world first, the Company's team of systems biologists and biochemists successfully targeted the FGF5 protein, a negative regulator of the hair cycle, and developed a range of innovative consumer products for hair loss, thinning and hair aging.
With a deep pipeline of new product development and operations in Australia, Japan and in the USA, Cellmid has grown its distribution footprint significantly since first launch in 2013.